Meredith Brantley leads implementation science for AstraZeneca’s US biopharmaceutical medical affairs teams, with a focus on policy evidence. Prior to joining AstraZeneca in 2022, Meredith led strategic planning, implementation, and evaluation of federal and state government public health programs through positions with the HHS Office of Infectious Disease Policy, CDC Division of Viral Hepatitis, HRSA Bureau of HIV/AIDS Division, and the Tennessee Department of Health.

Meredith received a Bachelor of Science degree in Cellular and Molecular Biology from the University of Michigan, a Master of Public Health degree in Epidemiology from Emory University, and a Doctorate in Behavioral Science from Johns Hopkins University.